Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Alan Haycox's publication output changed over time?
ScholarIQpublication output · 2001–2018
Output grew100% over the shown period — from 1 works in 2001 to 2 in 2018.
1
1
1
1
1
1
1
1
1
2
2001200320062009201020122013201520172018
What are the most-cited papers on Alan Haycox?
ScholarIQmost cited works
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Jakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, Bogusława Osińska, Harald Herholz, Kamila Wendykowska, Ott Laius, Saira Jan, Catherine Sermet, Corrine Zara, Marija Kalaba, Roland Gustafsson, Kristina Garuolienè, Alan Haycox, Silvio Garattini, Lars L. Gustafsson
BMC Health Services Research. 2010257 CitationsOPEN ACCESS
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study
Fiona McGill, Michael J. Griffiths, Laura Bonnett, Anna María Geretti, Benedict Michael, Nicholas J. Beeching, David McKee, Paula Scarlett, Ian Hart, Kenneth J. Mutton, Agam Jung, Guleed Adan, Alison Gummery, Wan Aliaa Wan Sulaiman, Katherine Ennis, Antony P. Martin, Alan Haycox, Alastair Miller, Tom Solomon, Adekola Adedeji, Ajdukiewicz Katharine, Birkenhead David, Blanchard Thomas, Cadwgan Antony, C. Warhurst David, Cheesbrough John, Cooke Richard, Croall John, Iain Crossingham, Dunbar James, Ellis Simon, Faris Camelia, Flegg Peter, Graham Clive, Gray Katherine, Hammersley Shirley, Jones Kevin, J. Ferrari Matthew, Ildikó Kustos, Susan Larkin, Mahawish Karim, Maxwell Sarah, Minton Jane, Mohandas Kavya, M Lewinter Martin, Ed Moran, M. Bishop Christopher, Pasztor Monika, Hassan Paraiso, Premchand Nikhil, Haris Rathur, Roberts Mark, Robinson Amy, Rosser Andrew, Schumacher Stefan, Silverdale Monty, Stanley Philip, T. C. H. Neil, Watt Alastair, Wiselka Martin
S23772524. 2018194 CitationsOPEN ACCESS
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery
Penny Whiting, R. Rishi Gupta, Jane Burch, Rubén Mújica-Mota, Kath Wright, Anthony G Marson, U Weishmann, Alan Haycox, Jos Kleijnen, Carol Forbes
Health Technology Assessment. 2006171 CitationsOPEN ACCESS
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnússon, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph Fadare, Øyvind Melien, Maciej Pomorski, Magdałene Władysiuk, Vanda Marković‐Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, D Tomek, Corrine Zara, Eduardo Diogène, Johanna C. Meyer, Rickard E. Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Alan Haycox
Frontiers in Public Health. 2018163 CitationsOPEN ACCESS
The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature
Dyfrig Hughes, A Bagust, Alan Haycox, Tom Walley
S145200904. 2001158 Citations
Related on ScholarIQ
University of Liverpool
Institution
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Paper
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study
Paper
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery
Paper
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Paper
The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature
Paper